Takuya Oguma Selected Research

Carboxylic Acids

11/2022

Discovery of a Tricyclic β-Lactam as a Potent Antimicrobial Agent against Carbapenem-Resistant Enterobacterales, Including Strains with Reduced Membrane Permeability and Four-Amino Acid Insertion into Penicillin-Binding Protein 3: Structure-Activity-Relationships and In Vitro and In Vivo Activities.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Takuya Oguma Research Topics

Disease

2	Infections 11/2022 - 01/2021
2	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 11/2019
1	Communicable Diseases (Infectious Diseases) 11/2022
1	autosomal dominant Spastic paraplegia 6 01/2022

Drug/Important Bio-Agent (IBA)

2	LactamsIBA 11/2022 - 01/2021
2	Amyloid (Amyloid Fibrils)IBA 01/2021 - 11/2019
1	2-aminothiazoleIBA 11/2022
1	Amino Acids FDA Link 11/2022
1	Carboxylic AcidsIBA 11/2022
1	Penicillin-Binding Proteins (Penicillin-Binding Protein)IBA 11/2022
1	himgalineIBA 01/2022
1	Peptides (Polypeptides)IBA 01/2021
1	sulfoxideIBA 01/2021
1	EnzymesIBA 11/2019
1	Proteins (Proteins, Gene)FDA Link 11/2019
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 11/2019